Join us as Dr. Durado Brooks, the Deputy Chief Medical Officer for the Screening Business Unit of Exact Sciences Corporation, outlines the state of the science around colorectal cancer screening.

Topics will include: epidemiologic trends in CRC incidence and mortality; demonstrated benefits of screening; CRC screening rate trends and the impact of the COVID-19 pandemic on screening; disparities in CRC screening and outcomes; discussion of similarities and differences between the screening guidelines from the ACS and the USPSTF; evidence supporting specific testing methods.

Register here.